Teleflex Incorporated (NYSE:TFX) Short Interest Update

Teleflex Incorporated (NYSE:TFX) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 493,600 shares, a decline of 26.9% from the November 15th total of 675,000 shares. Based on an average daily volume of 398,900 shares, the days-to-cover ratio is currently 1.2 days. Approximately 1.1% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on TFX shares. Truist Financial reaffirmed a “hold” rating and set a $227.00 price objective (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Mizuho lowered their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teleflex has a consensus rating of “Moderate Buy” and a consensus target price of $259.00.

Institutional Trading of Teleflex

Large investors have recently bought and sold shares of the stock. Point72 Asset Management L.P. raised its position in Teleflex by 564.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock valued at $65,304,000 after purchasing an additional 263,743 shares during the last quarter. Cooke & Bieler LP lifted its position in Teleflex by 23.3% during the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after buying an additional 172,335 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the last quarter. Ceredex Value Advisors LLC acquired a new stake in Teleflex in the 2nd quarter valued at about $25,550,000. Finally, FMR LLC raised its stake in shares of Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after acquiring an additional 111,086 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Performance

Shares of NYSE TFX traded down $3.17 during trading hours on Friday, reaching $180.14. The stock had a trading volume of 300,452 shares, compared to its average volume of 383,055. The company has a market cap of $8.37 billion, a price-to-earnings ratio of 36.33, a PEG ratio of 1.88 and a beta of 1.16. Teleflex has a twelve month low of $179.82 and a twelve month high of $257.85. The business’s fifty day moving average is $209.46 and its two-hundred day moving average is $220.67. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period last year, the firm earned $3.64 EPS. As a group, research analysts expect that Teleflex will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.75%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.